Correction: Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma

Correction: Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Leukemia 2024-02, Vol.38 (2), p.469-472
Hauptverfasser: Lenz, Georg, Hawkes, Eliza, Verhoef, Gregor, Haioun, Corinne, Thye Lim, Soon, Seog Heo, Dae, Ardeshna, Kirit, Chong, Geoffrey, Haaber, Jacob, Shi, Wei, Gorbatchevsky, Igor, Lippert, Susanne, Hiemeyer, Florian, Piraino, Paolo, Beckmann, Georg, Peña, Carol, Buvaylo, Viktoriya, Childs, Barrett H., Salles, Gilles
Format: Artikel
Sprache:eng
Schlagworte:
631/67/1059/602
692/699/67/1990/291/1621/1915
Cancer Research
Correction
Critical Care Medicine
Hematology
Intensive
Internal Medicine
Medicine
Medicine & Public Health
Oncology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:0887-6924
1476-5551
DOI:10.1038/s41375-023-02133-2